The Patent Finder

Surface Oncology, Inc.

Also on record
Records under this name other than the patents Surface Oncology, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 8 patents it holds.

Showing 1 to 9 of 9 · Back to Surface Oncology, Inc.

PatentTitleStatus Expires Confidence
US 9,650,441Anti-CD47 antibodies and methods of use
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,803,016Anti-CD47 antibodies and methods of use
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,570,201Anti-CD47 antibodies and methods of use
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,312,783Antibody Molecules to CD73 and Uses Thereof
Formerly held
In force
 · High confidence
In forceHigh confidence
US 12,496,342Anti-CCR8 Antibodies and Uses Thereof
Formerly held
In force
 · High confidence
In forceHigh confidence
US 11,859,000ANTI-CCR8 Antibodies and Uses Thereof
Formerly held
In force
 · High confidence
In forceHigh confidence
US 10,793,637Antibodies That Bind CD39 and Uses Thereof
Lapsed on the fee record
Ended Oct 6, 2024 · High confidence
Lapsed on the fee recordEnded Oct 6, 2024High confidence
US 10,738,128Antibodies That Bind CD39 and Uses Thereof
Lapsed on the fee record
Ended Aug 11, 2024 · High confidence
Lapsed on the fee recordEnded Aug 11, 2024High confidence
US 10,442,858Anti-CD47 antibodies and methods of use
Lapsed on the fee record
Ended Oct 15, 2023 · From the USPTO record
Lapsed on the fee recordEnded Oct 15, 2023From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited